Safety and Effectiveness of Sonu for Pediatric Nasal Congestion

Description

To demonstrate the safety and effectiveness of Sonu for the treatment of pediatric patients with moderate to severe nasal congestion.

Conditions

Nasal Congestion and Inflammations

Talk to us

Study Overview

On this page

Study Details

Study overview

To demonstrate the safety and effectiveness of Sonu for the treatment of pediatric patients with moderate to severe nasal congestion.

Safety and Effectiveness of Sonu Acoustic Resonance Therapy for the Treatment of Pediatric Patients With Moderate to Severe Nasal Congestion.

Safety and Effectiveness of Sonu for Pediatric Nasal Congestion

Condition
Nasal Congestion and Inflammations
Intervention / Treatment

-

Contacts and Locations

Portola Valley

Crescendo MD, Portola Valley, California, United States, 94028

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * Pediatric subjects between the ages of 12 to 21 years
  • * Present with symptoms of nasal congestion for 1 month or more prior to treatment
  • * Have a 24 hour reflective nasal congestion subscore of the TNSS of 2 or more on a 0 to 3 scale at the time of screening
  • * Head, nasal or sinus surgery within 3 months
  • * Sinus infection diagnosed within the last month, or rhinitis medicamentosa
  • * Documented history of nasal polyposis or mass
  • * Pregnancy

Ages Eligible for Study

12 Years to 21 Years

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

Third Wave Therapeutics,

Alan Greene, MD, PRINCIPAL_INVESTIGATOR, Crescendo MD

Study Record Dates

2025-06-30